Interventions addressing fear of cancer recurrence: challenges and future perspectives

Curr Opin Oncol. 2022 Jul 1;34(4):279-284. doi: 10.1097/CCO.0000000000000837. Epub 2022 Jun 22.

Abstract

Purpose of review: Fear of cancer recurrence (FCR) is a common concern among cancer survivors and support for FCR is one of the most cited unmet needs. High FCR was found to be related to increased use of healthcare services, specifically primary healthcare and medical consultations, and lower quality of life. In the past decade screening instruments for FCR and interventions have been developed and proven effective.

Recent findings: Systematic reviews and meta-analyses have shown that psychological treatments are effective for reducing FCR. The cost-effectiveness of FCR interventions could be increased by considering stepped or matched models for supportive care. Despite availability of evidence-based interventions, the proposed care models are not implemented and most cancer survivors still do not benefit from supportive care.

Summary: The time is right to focus on implementation of FCR interventions into clinical practice. The complexity of optimizing FCR care is characterized by barriers and facilitators in the domains of patients, healthcare professionals, healthcare organizations and the broader economic, and political context. The main challenge for future research is to address these issues so that former investments in high-quality FCR intervention research will pay out in actual practice changes in the benefit of cancer survivors.

Publication types

  • Review

MeSH terms

  • Cancer Survivors*
  • Cost-Benefit Analysis
  • Fear / psychology
  • Humans
  • Neoplasm Recurrence, Local / prevention & control
  • Quality of Life*